Cornell researchers have identified a new way to measure DNA torsional stiffness – how much resistance the helix offers when twisted – information that can potentially shed light on how cells work.
A University of Miami Miller School of Medicine biochemistry researcher has found that a nanoparticle drug delivery system can reduce HIV/AIDS viral reservoirs in the brain that normally contribute to neurological problems.
Imagine if you could attach something to your skin without needing glue. A biosensor, a watch, a communications device, a fashion accessory — the possibilities are endless. Thanks to a discovery at Binghamton University, State University of New York, that time could be closer than you think.
Mayo Clinic researchers and colleagues at Massachusetts Institute of Technology (MIT) have developed a rapid-sealing paste that can stop bleeding organs independent of clotting. The details are published in Nature Biomedical Engineering.
The inspiration for this paste? Barnacles.
Pharmaceutical and biotechnology companies topped the 2021 RQ Top 50 list of the most innovative U.S. companies. The annual ranking identifies the smartest R&D spenders - those companies that both spend big (at least $100 million in R&D) and provide the greatest returns to shareholders from that investment.
With the recent announcement of the RegeneratOR Test Bed to support regenerative medicine start up companies, the Wake Forest Institute for Regenerative Medicine (WFIRM) and the RegenMed Development Organization (RemDO) are embarking on the next step – to help create the future workforce.
Despite assumptions, dsRNA has traits that make it stand apart from the more common single-stranded RNA. The finding has implications for a range of fields
A new University of Kentucky College of Medicine study published in the Journal of Biological Chemistry provides foundational information about SARS-CoV-2’s spike protein.
This transaction will expand BioIVT’s biospecimen collection network by approximately 150 sites in the US, UK, and Europe and broaden its offerings for drug and diagnostic developers.
Scientists have developed a rapid, highly accurate test to detect antibodies against the spike protein of SARS-CoV-2 in human serum, opening a new avenue for understanding the full extent of the pandemic and evaluating the effectiveness of vaccines.
The NCCN Oncology Research Program (ORP) announces projects that have been selected for funding to evaluate neratinib in various tumor types, supported by a grant from Puma Biotechnology, Inc.
Scientists have uncovered a way to control many genes in engineered yeast cells, opening the door to more efficient and sustainable production of bio-based products.
The Polo Tecnologico Piemontese (PTP) is born in Candiolo (Turin), a hub of innovative companies that will host avant-garde technological companies and research institutes dedicated to medicine and which sees the HBW Group * as the leader.
Researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval.
Harrisburg University of Science and Technology and The Baruch S. Blumberg Institute have teamed to offer graduate-level biotechnology certificates to prepare working professionals with workforce and leadership skills within the biotechnology industry.
Beginning Fall 2021 semester, the Biotechnology Certificate Program will be offered in partnership with The Blumberg Institute. The Blumberg Institute is the nation’s leading translational research organization dedicated to finding a cure for hepatitis B and liver cancer.
Scientists at UC San Francisco have shown that gene-edited cellular therapeutics can be used to successfully treat cardiovascular and pulmonary diseases, potentially paving the way for developing less expensive cellular therapies to treat diseases for which there are currently few viable options.
The U.S. Department of Energy (DOE) today awarded $45.5 million for research projects geared towards understanding and harnessing nature’s biological processes to produce clean biofuels and bioproducts.
In a long career full of scientific accomplishments, Brian Davison counts among his many successes the formation of Oak Ridge National Laboratory’s LGBTQIA+ employee group and helping gay and lesbian staff at the lab navigate a sometimes tricky landscape has been among his most meaningful experiences.
Westbury, NY – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the acquisition of Valley Biomedical Products & Services, Inc. located in Winchester, VA.
Mary Dunlop leads a team at Boston University that uses multi-disciplinary approaches to improve the amount of biofuel that certain microbes can produce. These microbes can produce replacements for gasoline, diesel, and jet fuel.
An accurate, non-invasive, and low-cost method of testing for COVID-19 using samples taken from the screens of mobile phones has been developed by a team led by UCL researchers at Diagnosis Biotech.
Jin Kim Montclare, professor of chemical and biomolecular engineering led a team who previously reported a responsive hydrogel formed using a coiled-coil protein. The team expanded their studies to identify the gelation of Q protein at distinct temperatures and pH conditions.
The American Society of Anesthesiologists (ASA) today announced Heron Therapeutics, a commercial-stage biotechnology company, as an ASA Industry Supporter for the third year, supporting the work of the Society and physician anesthesiologists to reduce reliance on opioids during or following surgical procedures and ensuring that non-opioid alternatives are available to patients.
A hydrogel that forms a barrier to keep heart tissue from adhering to surrounding tissue after surgery was developed and successfully tested in rodents by a team of University of California San Diego researchers. The team of engineers, scientists and physicians also conducted a pilot study on porcine hearts, with promising results.
They describe their work in the June 18, 2021 issue of Nature Communications.
UC San Diego School of Medicine researchers discovered that the enzyme RNA polymerase II recognizes and transcribes artificially added base pairs in genetic code, a new insight that could help advance the development of new vaccines and medicines.
GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager (TriKE™) protein biologic technology platform, today announced that it will provide a corporate update at the upcoming Raymond James Human Health Innovation Conference on Tuesday, June 22, 2021 at 11:20 AM ET.
The Southwest National Primate Research Center (SNPRC) at Texas Biomed has been awarded more than $37 million from the National Institutes of Health to continue operations into 2026. The P51 grant, given by the NIH Office of Research Infrastructure Programs, provides essential funding to house and care for nearly 2,500 non-human primates that are part of life-science research programs at Texas Biomed and partners around the globe.
Inspired by kirigami, the Japanese art of folding and cutting paper to create three-dimensional structures, MIT engineers and their collaborators have designed a new type of stent that could be used to deliver drugs to the gastrointestinal tract, respiratory tract, or other tubular organs in the body.
Scientists from the University of Bristol have pioneered a new approach to help biological engineers both harness and design the evolutionary potential of new biosystems. Their concept of the ‘evotype’ lays a foundation for the next generation of stable, safe and self-improving biotechnologies.
Elementa Labs will connect health care startup companies with Mount Sinai’s vast network of research and clinical experts to advance groundbreaking health care innovations.
A new 3D bioprinter developed by UC San Diego nanoengineers operates at record speed—it can print a 96-well array of living human tissue samples within 30 minutes. The technology could help accelerate high-throughput preclinical drug screening and make it less costly.
When we inhale isolated coronavirus particles, more than 65% reach the deepest region of our lungs where damage to cells can lead to low blood oxygen levels, new research has discovered, and more of these aerosols reach the right lung than the left.
A University of Alabama in Huntsville (UAH) doctoral student in biotechnology will travel to France under a Chateaubriand Fellowship in Science, Technology, Engineering, Mathematics & Biology-Health to help research a possible biological early warning system for hazardous chemicals.
A Cornell University-developed technology provides beekeepers, consumers and farmers with an antidote for deadly pesticides, which kill wild bees and cause beekeepers to lose around a third of their hives every year on average.
The La Jolla Institute for Immunology (LJI) is partnering with Synbal, Inc., a preclinical biotechnology company based in San Diego, CA, to develop multi-gene, humanized mouse models for COVID-19 research. The research at LJI will be led by Professor Sujan Shresta, Ph.D., a member of the Institute’s Center for Infectious Disease and Vaccine Research.
The way the human brain works remains, to a great extent, a topic of controversy. One reason is our limited ability to study neuronal processes at the level of single cells and capillaries across the entire living brain without employing highly invasive surgical methods. This limitation is now on the brink of change.
Cellphire Therapeutics, Inc., a biotechnology company developing next-generation platelet-based hemostatic therapeutics for application across multiple medical indications, announced today that the first patient has been dosed in the company's Phase 2 dose-ranging study of Thrombosomes®, a platelet-based freeze-dried hemostatic agent, in bleeding patients with thrombocytopenia. The study will evaluate the safety and efficacy of infusing multiple dose levels of Thrombosomes versus standard liquid stored platelets.
A team of researchers, led by a University of Minnesota associate professor, have developed a polymer “wafer” that, when placed under the tongue, can effectively deliver and preserve protein-based vaccines for diseases. The research could open the door for vaccines that can be more easily produced and distributed to communities around the world.
Not all embryo transfers succeed, which gives rise to the practice of freezing extra embryos from an IVF cycle for future transfers. This allows those with at-risk fertility, due to age or treatments such as chemotherapy, to delay their transfer. In the journal Biomicrofluidics, researchers introduce a standalone microfluidics system to automate the process of embryo vitrification of replacing water with cryoprotectants, which exposes embryos to a slow and constantly increasing concentration of cryoprotectants.
In an important step toward the clinical application of synthetic biology, Rice University researchers have engineered a bacterium with the necessary capabilities for diagnosing a human disease.